ELI LILLY & Co Executive Compensation
Named executive officer pay as disclosed in the company’s lly-20260317.htm proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.
$36,698,337
David A. Ricks, Chief Executive Officer — total compensation
$1,700,000
base salary
Healthcare
industry
| Executive | Title | Base salary | Total compensation |
|---|---|---|---|
| David A. Ricks | Chair, President, and Chief Executive Officer Chair, President, and Chief Executive Officer | $1,700,000 | $36,698,337 |
| Daniel M. Skovronsky, M.D., Ph.D. | $1,490,385 | $17,786,576 | |
| Anat Hakim | Executive Vice President, General Counsel and Secretary Executive Vice President, General Counsel and Secretary | $1,000,000 | $9,845,518 |
| Lucas Montarce | Executive Vice President and Chief Financial Officer | $1,000,000 | $8,483,315 |
| Jake Van Naarden | $920,192 | $7,586,097 |
Source: ELI LILLY & Co Definitive Proxy Statement (DEF 14A), filed lly-20260317.htm with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.
Other Healthcare companies
UNITEDHEALTH GROUP INC
Healthcare
$60,938,062
Stephen Hemsley, CEO
JOHNSON & JOHNSON
Healthcare
$32,758,111
J. Duato, CEO
AbbVie Inc.
Healthcare
$32,530,984
Robert A. Michael, CEO
GILEAD SCIENCES, INC.
Healthcare
$28,437,198
Daniel P, CEO
PFIZER INC
Healthcare
$27,585,301
A. Bourla, CEO
AMGEN INC
Healthcare
$24,693,120
Robert A. Bradway, CEO
